The first industry-dedicated meeting focused on optimizing clinical trial design, efficacy assessment, target identification, and expansion beyond orphan diseases.

An intensive two-day conference convening international experts at the forefront of research and treatment of bone marrow failure disease.

The EHA Annual Congress is a forum for original unpublished data, sharing of ideas about hematological innovation, and dissemination of evidence-based knowledge of primary clinical relevance.

The world’s largest and oldest complement conference, this meeting attracts more than 500 members from the global complement community.

Please save the date for this gathering of industry professionals from across the globe who are interested in the study and treatment of PNH.

The world’s most comprehensive hematology event of the year, attracting more than 25,000 hematology professionals from across the globe and from every subspecialty.